Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Nilotinib can cause keratosis pilaris, a skin condition.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Biological therapy boosts the immune system to effectively fight melanoma.

Cancer treatments often cause skin, nail, and hair problems.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Tadalafil and Finasteride may help treat aggressive melanoma.

WYE-130600 may cause skin thickening and irritation.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Hedgehog pathway inhibitors could be effective in treating melanoma.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Sorafenib often causes skin side effects, indicating effective cancer treatment.